Your browser doesn't support javascript.
loading
An expeditious synthesis of the MDM2-p53 inhibitor AM-8553.
Lucas, Brian S; Fisher, Benjamin; McGee, Lawrence R; Olson, Steven H; Medina, Julio C; Cheung, Eugene.
Affiliation
  • Lucas BS; Department of Medicinal Chemistry, Amgen, Inc., S. San Francisco, California 94080, United States. blucas@amgen.com
J Am Chem Soc ; 134(30): 12855-60, 2012 Aug 01.
Article in En | MEDLINE | ID: mdl-22734631
ABSTRACT
The development of the structurally complex MDM2/p53 inhibitor AM-8553 was impeded by the low yield of the initial synthesis. A second generation synthesis is described that features a Noyori dynamic kinetic resolution, a highly diastereoselective allylation, and a novel oxazoline-assisted piperidinone forming reaction to provide AM-8553 in 35.6% yield and 11 steps.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Piperidones / Tumor Suppressor Protein p53 / Proto-Oncogene Proteins c-mdm2 / Acetates / Antineoplastic Agents Limits: Humans Language: En Year: 2012 Type: Article

Full text: 1 Database: MEDLINE Main subject: Piperidones / Tumor Suppressor Protein p53 / Proto-Oncogene Proteins c-mdm2 / Acetates / Antineoplastic Agents Limits: Humans Language: En Year: 2012 Type: Article